Discovery Research Platform for Infection

Discovery Research Platform for Infection

track_changes Track Tracking Be alerted when new articles are added in this gateway (manage your tracking alerts via your account) Stop tracking this gateway
1-18 of 18 ARTICLES
https://doi.org/10.12688/wellcomeopenres.23580.1
Study Protocol metrics AWAITING PEER REVIEW
Characteristics and HIV-related Engagement of Male Sexual Partners of Female Sex Workers in Sub-Saharan Africa (SSA): a Scoping Review Protocol
[version 1; peer review: awaiting peer review]
Peer Reviewers Invited
  • Funder
  • Wellcome Trust
PUBLISHED 22 Apr 2025
https://doi.org/10.12688/wellcomeopenres.23363.1
Study Protocol metrics
Efficacy and Safety of Long-acting Injectable Cabotegravir and Rilpivirine in Improving HIV-1 Control in sub-Saharan Africa: Protocol for a Phase 3b Open-Label Randomized Controlled Trial (IMPALA)
[version 1; peer review: 2 approved]
Peer Reviewers Eisuke Adachi; Stefano Rusconi
  • Funder
  • Janssen Pharmaceutica NV, a company of Johnson & Johnson
PUBLISHED 28 Mar 2025
https://doi.org/10.12688/wellcomeopenres.23009.2
Research Article metrics
Revised
Implementation of a genotyped African population cohort, with virtual follow-up: A feasibility study in the Western Cape Province, South Africa
[version 2; peer review: 2 approved, 1 approved with reservations, 1 not approved]
Peer Reviewers Emilio Di Maria; Hermina Jakupović; Alexander J Mentzer and Amanda Chong; Maik Pietzner
  • Funders
  • Wellcome Trust
  • National Health and Medical Research Council
  • NIH
  • Gates Foundation
  • South Africa Medical Research Council
  • UK Research and Innovation
LATEST VERSION PUBLISHED 13 Jan 2025
https://doi.org/10.12688/wellcomeopenres.17660.3
Research Article metrics
Revised
Pharmacokinetics of antitubercular drugs in patients hospitalized with HIV-associated tuberculosis: a population modeling analysis
[version 3; peer review: 2 approved, 1 approved with reservations]
Peer Reviewers Oscar Della Pasqua; Jotam Pasipanodya; Fajri Gafar
  • Funders
  • Wellcome Trust
  • NRF
  • Francis Crick Institute
  • South African Medical Research Council through its TB and HIV Collaborating Centres Programme with funds received from the National Department of Health
  • National Institutes of Health
  • EDCTP
  • South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation (NRF) of South Africa
LATEST VERSION PUBLISHED 01 Mar 2024
https://doi.org/10.12688/wellcomeopenres.15824.2
Research Article metrics
Revised
A multi-parameter diagnostic clinical decision tree for the rapid diagnosis of tuberculosis in HIV-positive patients presenting to an emergency centre
[version 2; peer review: 2 approved, 1 approved with reservations]
Peer Reviewers Jim Connoly; Maria Teresa Giordani; Peter MacPherson
  • Funders
  • Wellcome Trust
  • South African Medical Research Council
  • National Research Foundation
LATEST VERSION PUBLISHED 12 May 2022
https://doi.org/10.12688/wellcomeopenres.16474.2
Review metrics
Revised
Host Directed Therapies for Tuberculous Meningitis
[version 2; peer review: 2 approved]
Peer Reviewers Fabrice Bonnet; Vishwanath Venketaraman
  • Funders
  • Wellcome Trust
  • Cancer Research UK
  • Francis Crick Institute
  • Medical Research Council
  • Meningitis Now
  • National Institutes of Health
  • UK Research and Innovation
LATEST VERSION PUBLISHED 01 Jul 2021
https://doi.org/10.12688/wellcomeopenres.16783.1
Study Protocol metrics
Study protocol for a phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for HIV-associated tuberculous meningitis [LASER-TBM]
[version 1; peer review: 2 approved]
Peer Reviewers Julie Huynh; Frederic Ello
  • Funders
  • Wellcome Trust
  • European and Developing Countries Clinical Trials Partnership
  • Cancer Research UK
  • Meningitis Now
  • Medical Research Council
  • National Institutes of Health
  • National Research Foundation
  • UK Research and Innovation
PUBLISHED 01 Jun 2021
https://doi.org/10.12688/wellcomeopenres.16597.1
Study Protocol metrics
AntiRetroviral Therapy In Second-line: investigating Tenofovir-lamivudine-dolutegravir (ARTIST): protocol for a randomised controlled trial
[version 1; peer review: 2 approved, 1 approved with reservations]
Peer Reviewers Stephen Ian Walimbwa; Laura Waters; Loice Achieng Ombajo
  • Funders
  • Wellcome Trust
  • Médecins Sans Frontières
  • Department of Science and Technology, Republic of South Africa
  • National Research Foundation
PUBLISHED 17 Feb 2021
https://doi.org/10.12688/wellcomeopenres.15506.3
Review metrics
Revised
Recent Developments in Tuberculous Meningitis Pathogenesis and Diagnostics
[version 3; peer review: 3 approved]
Peer Reviewers James E. Scriven; Joseph Zunt; Michael J. Griffiths
  • Funders
  • Wellcome Trust
  • National Institute of Neurological Disorders and Stroke
  • European and Developing Countries Clinical Trials Partnership
  • Cancer Research UK
  • Meningitis Now
  • National Research Foundation of South Africa
LATEST VERSION PUBLISHED 28 Jan 2021
https://doi.org/10.12688/wellcomeopenres.16506.1
Open Letter metrics
Before the whistle blows: developing new paradigms in tuberculosis screening to maximise benefit and minimise harm
[version 1; peer review: 1 approved, 1 approved with reservations]
Peer Reviewers Daniel Gemechu Datiko; Nargiza Parpieva and Laziz Turaev
  • Funder
  • Wellcome Trust
PUBLISHED 21 Jan 2021
https://doi.org/10.12688/wellcomeopenres.16473.1
Study Protocol metrics
Standard versus double dose dolutegravir in patients with HIV-associated tuberculosis: a phase 2 non-comparative randomised controlled (RADIANT-TB) trial
[version 1; peer review: 2 approved]
Peer Reviewers Derek J. Sloan; Kelly Dooley
  • Funders
  • Wellcome Trust
  • Wellcome Trust - Wellcome Centre for Infectious Diseases Research in Africa
PUBLISHED 11 Jan 2021
https://doi.org/10.12688/wellcomeopenres.15056.3
Study Protocol metrics
Revised
The diagnosis of tuberculous meningitis in adults and adolescents: protocol for a systematic review and individual patient data meta-analysis to inform a multivariable prediction model
[version 3; peer review: 2 approved]
Peer Reviewers Ravindra Kumar Garg; Kym I.E. Snell
  • Funder
  • Wellcome Trust
LATEST VERSION PUBLISHED 04 Jan 2021
https://doi.org/10.12688/wellcomeopenres.15497.2
Open Letter metrics
Revised
Standardized approaches for clinical sampling and endpoint ascertainment in tuberculous meningitis studies
[version 2; peer review: 2 approved]
Peer Reviewers William P. Howlett; Benedict D. Michael
  • Funders
  • Wellcome Trust
  • Cancer Research UK
  • Meningitis Now
  • Fogarty International Center of the National Institutes of Health
  • European & Developing Countries Clinical Trials Partnership
  • UK Medical Research Council
  • National Institutes of Health
LATEST VERSION PUBLISHED 03 Jun 2020
https://doi.org/10.12688/wellcomeopenres.15501.3
Open Letter metrics
Revised
Management of intracranial tuberculous mass lesions: how long should we treat for?
[version 3; peer review: 3 approved]
Peer Reviewers Jerome H. Chin; Benedict Michael; Julie Higashi
  • Funders
  • Wellcome Trust
  • National Research Foundation SARChI Chair in Clinical Neurosciences
  • Fogarty International Center
  • National Institutes of Health
  • South African Medical Research Council
  • Department of Science and Technology, Republic of South Africa
  • National Research Foundation, South Africa
LATEST VERSION PUBLISHED 26 Feb 2020
https://doi.org/10.12688/wellcomeopenres.15573.1
Open Letter metrics
Knowledge gaps and research priorities in tuberculous meningitis
[version 1; peer review: 3 approved]
Peer Reviewers Christopher Vinnard; Jamie Rylance; Hardeep Singh Malhotra
  • Funders
  • Wellcome Trust
  • European and Developing Countries Clinical Trials Partnership
  • Cancer Research UK
  • Francis Crick Institute
  • Department for International Development, UK Government
  • Meningitis Now
  • Medical Research Council
  • National Research Foundation
  • UK Research and Innovation
PUBLISHED 28 Nov 2019
https://doi.org/10.12688/wellcomeopenres.15516.1
Review metrics
Neurocognitive and functional impairment in adult and paediatric tuberculous meningitis
[version 1; peer review: 2 approved]
Peer Reviewers Reuben Robbins; Monica Marta
  • Funders
  • Wellcome Trust
  • Cancer Research UK
  • Meningitis Now
  • National Research Foundation of South Africa
  • National Institutes of Health
  • Newton Fund
PUBLISHED 13 Nov 2019
https://doi.org/10.12688/wellcomeopenres.15332.1
Research Article metrics
Variation in pre-therapy levels of selected Mycobacterium tuberculosis transcripts in sputum and their relationship with 2-month culture conversion
[version 1; peer review: 2 approved with reservations]
Peer Reviewers Michelle B. Ryndak; Kalpana Sriraman and Nerges Mistry
  • Funders
  • Wellcome Trust
  • Medical Research Council
  • Cancer Research UK
  • FP7 People: Marie-Curie Actions
  • Seventh Framework Programme
  • National Research Foundation
PUBLISHED 05 Jul 2019
https://doi.org/10.12688/wellcomeopenres.14073.3
Method Article metrics
Revised
ANIMA: Association network integration for multiscale analysis
[version 3; peer review: 2 approved, 1 approved with reservations]
Peer Reviewers Christopher L. Plaisier; James A. Eddy; Emre Guney
  • Funders
  • Wellcome Trust
  • Francis Crick Institute
  • Hasso Plattner Foundation
  • Medical Research Council (South Africa)
  • Newton Fund
LATEST VERSION PUBLISHED 14 Nov 2018
1-18 of 18 ARTICLES
Our News

Are you a Wellcome-funded researcher?

If you are a previous or current Wellcome grant holder, sign up for information about developments, publishing and publications from Wellcome Open Research.

You must provide your first name
You must provide your last name
You must provide a valid email address
You must provide an institution.

Thank you!

We'll keep you updated on any major new updates to Wellcome Open Research

Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.